EUVIMEDEUVIMED entdecken
Crossref

Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of papillary thyroid carcinoma via the BRAF-ERK1/2-P53 signaling pathway

Yuanhao Su, Lin Mei, Yongke Wu, Cheng Li, Tiantian Jiang, Yiyuan Zhao, Xin Feng, Tingkai Sun, Yunhao Li, Zhidong Wang, Yuanyuan Ji

Journal of Endocrinological Investigation · 2024

DOI: 10.1007/s40618-024-02481-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinological Investigation, 2024. Verfasst von Yuanhao Su und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric General Surgery, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710004, Shaanxi, China. Hauptthemen laut MEDLINE: Thyroid Cancer, Papillary, Thyroid Neoplasms, Proto-Oncogene Proteins B-raf, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: the Natural Science Basic Research Program of Shaanxi, the Exploration Research Foundation of the Second Affiliated Hospital of Xi'an Jiaotong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid Cancer, PapillaryThyroid NeoplasmsProto-Oncogene Proteins B-rafTumor Suppressor Protein p53Xenotropic and Polytropic Retrovirus ReceptorMAP Kinase Signaling SystemHumansAnimalsDisease ProgressionFemaleMiceMaleCell ProliferationMiddle AgedPrognosisGene Expression Regulation, NeoplasticSignal TransductionCell Movement

Stichwörter der Autor:innen

BRAFERK1/2P53Papillary thyroid carcinoma (PTC)PrognosisTherapeutic targetXenotropic and polytropic retrovirus receptor 1 (XPR1)

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, humanTumor Suppressor Protein p53Xenotropic and Polytropic Retrovirus ReceptorXPR1 protein, humanTP53 protein, human

Autor:innen und Institutionen

  • Department of Geriatric General Surgery, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710004, Shaanxi, China.
  • Scientific Research Center and Precision Medical Institute, The Second Affiliated Hospital, Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, Shaanxi, China.
  • Department of Geriatric General Surgery, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710004, Shaanxi, China. xawzd@163.com.
  • Scientific Research Center and Precision Medical Institute, The Second Affiliated Hospital, Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, Shaanxi, China. jiyuanyuan1234@163.com.

Förderung

  • the Natural Science Basic Research Program of Shaanxi
  • the Exploration Research Foundation of the Second Affiliated Hospital of Xi'an Jiaotong University

Zitieren

APA

Su, Y., Mei, L., Wu, Y., Li, C., Jiang, T., Zhao, Y., Feng, X., Sun, T., Li, Y., Wang, Z., & Ji, Y. (2024). Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of papillary thyroid carcinoma via the BRAF-ERK1/2-P53 signaling pathway. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-024-02481-5

Vancouver

Su Y, Mei L, Wu Y, Li C, Jiang T, Zhao Y, et al. Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of papillary thyroid carcinoma via the BRAF-ERK1/2-P53 signaling pathway. Journal of Endocrinological Investigation. 2024. doi:10.1007/s40618-024-02481-5

BibTeX
@article{Su2024,
  author = {Su, Yuanhao and Mei, Lin and Wu, Yongke and Li, Cheng and Jiang, Tiantian and Zhao, Yiyuan and Feng, Xin and Sun, Tingkai and Li, Yunhao and Wang, Zhidong and Ji, Yuanyuan},
  title = {Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of papillary thyroid carcinoma via the BRAF-ERK1/2-P53 signaling pathway},
  journal = {Journal of Endocrinological Investigation},
  year = {2024},
  doi = {10.1007/s40618-024-02481-5}
}
Kostenlos starten →